Julia Alcaide

1.1k total citations
60 papers, 605 citations indexed

About

Julia Alcaide is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Julia Alcaide has authored 60 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Julia Alcaide's work include Colorectal Cancer Treatments and Studies (19 papers), Genetic factors in colorectal cancer (14 papers) and Gastric Cancer Management and Outcomes (8 papers). Julia Alcaide is often cited by papers focused on Colorectal Cancer Treatments and Studies (19 papers), Genetic factors in colorectal cancer (14 papers) and Gastric Cancer Management and Outcomes (8 papers). Julia Alcaide collaborates with scholars based in Spain, United States and United Kingdom. Julia Alcaide's co-authors include Juan Nácher, Maximino Redondo, Elísabeth Pérez-Ruiz, Antonio Rueda, Isabel Rodrigo, Julio Sanjuán, Ramón Guirado, José Miguel Blasco‐Ibáñez, Francisco Rivas‐Ruiz and Carlos Crespo and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Julia Alcaide

52 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julia Alcaide Spain	14	285	112	95	91	90	60	605
Dominique Genet France	14	422 1.5×	226 2.0×	82 0.9×	92 1.0×	75 0.8×	41	889
J.L. Misset France	13	357 1.3×	124 1.1×	120 1.3×	121 1.3×	43 0.5×	39	733
Nicole Williams United States	15	349 1.2×	165 1.5×	35 0.4×	139 1.5×	32 0.4×	64	677
Walter Cosolo Australia	12	175 0.6×	122 1.1×	54 0.6×	178 2.0×	43 0.5×	22	581
Fangyuan Hu China	16	367 1.3×	136 1.2×	36 0.4×	164 1.8×	44 0.5×	40	765
Kenji Kuroda Japan	16	181 0.6×	160 1.4×	47 0.5×	222 2.4×	177 2.0×	69	722
Melanie R. Palomares United States	14	154 0.5×	152 1.4×	65 0.7×	197 2.2×	39 0.4×	35	683
Selene Capitanio Italy	14	100 0.4×	97 0.9×	44 0.5×	178 2.0×	54 0.6×	34	618
Benjamin Lyons United States	9	468 1.6×	182 1.6×	76 0.8×	146 1.6×	39 0.4×	9	868
Emilia Quattrocchi United States	15	131 0.5×	50 0.4×	60 0.6×	222 2.4×	46 0.5×	27	847

Countries citing papers authored by Julia Alcaide

Since Specialization

Citations

This map shows the geographic impact of Julia Alcaide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Alcaide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Alcaide more than expected).

Fields of papers citing papers by Julia Alcaide

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Alcaide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Alcaide. The network helps show where Julia Alcaide may publish in the future.

Co-authorship network of co-authors of Julia Alcaide

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Alcaide. A scholar is included among the top collaborators of Julia Alcaide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Alcaide. Julia Alcaide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Montagut, Clara, Joana Vidal, Vicente Alonso-Orduña, et al.. (2025). LBA33 Circulating tumor (ct) DNA-guided anti-EGFR rechallenge strategy in metastatic colorectal cancer (mCRC): Final results of the phase II randomized CITRIC trial. Annals of Oncology. 36. S1576–S1577.

Alcaide, Julia, Hatim Boughanem, Marilina García‐Aranda, et al.. (2025). Long‐term prognostic implications of type 2 diabetes mellitus in colorectal cancer patients. Colorectal Disease. 27(10). e70250–e70250.

Alonso-Orduña, Vicente, F. Rivera Herrero, L. Layos Romero, et al.. (2024). 511MO Third line rechallenge with cetuximab (Cet) and irinotecan in circulating tumor DNA (ctDNA) selected metastatic colorectal cancer (mCRC) patients: The randomized phase II CITRIC trial. Annals of Oncology. 35. S433–S434. 8 indexed citations

Alcaide, Julia, Clara Bueno-Fernández, Carmen Sandi, et al.. (2024). Long term effects of peripubertal stress on the thalamic reticular nucleus of female and male mice. Neurobiology of Disease. 200. 106642–106642. 1 indexed citations

Alcaide, Julia, et al.. (2024). Long-term effects of a double hit murine model for schizophrenia on parvalbumin expressing cells and plasticity-related molecules in the thalamic reticular nucleus and the habenula. Translational Psychiatry. 14(1). 450–450. 2 indexed citations

Pericay, Carles, Clara Montagut, Juan José Reina, et al.. (2024). SEOM-GEMCAD-TTD clinical guidelines for the adjuvant treatment of colon cancer (2023). Clinical & Translational Oncology. 26(11). 2812–2825.

André, Thierry, Tae Won Kim, Benny Vittrup Jensen, et al.. (2023). LBA32 Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the randomized phase III KEYNOTE-177 study. Annals of Oncology. 34. S1271–S1272. 12 indexed citations

Alonso-Orduña, Vicente, Jaime Feliú, Ana Fernández Montés, et al.. (2023). 605P First-line chemotherapy with or without targeted therapies in metastatic colorectal cancer: The GEMCAD 14-01 prospective cohort. Annals of Oncology. 34. S435–S435.

Clemente‐Postigo, Mercedes, et al.. (2023). 8-Oxoguanine DNA Glycosylase 1 Upregulation as a Risk Factor for Obesity and Colorectal Cancer. International Journal of Molecular Sciences. 24(6). 5488–5488. 4 indexed citations

10.

André, Thierry, Kai‐Keen Shiu, Benny Vittrup Jensen, et al.. (2021). O-8 Final overall survival for the phase 3 KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer. Annals of Oncology. 32. S220–S221. 1 indexed citations

11.

Salas‐Benito, Diego, Ibón Tamayo, Uxua Mancheño, et al.. (2021). The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes. British Journal of Cancer. 124(6). 1138–1149. 15 indexed citations

12.

Bueno-Fernández, Clara, Marta Pérez-Rando, Julia Alcaide, et al.. (2021). Long term effects of peripubertal stress on excitatory and inhibitory circuits in the prefrontal cortex of male and female mice. Neurobiology of Stress. 14. 100322–100322. 20 indexed citations

13.

Boughanem, Hatim, Gracia María Martín‐Núñez, Esperanza Torres, et al.. (2020). Impact of Tumor LINE-1 Methylation Level and Neoadjuvant Treatment and Its Association with Colorectal Cancer Survival. Journal of Personalized Medicine. 10(4). 219–219. 12 indexed citations

14.

Beveridge, Robert Díaz, Ana Fernández Montés, Julia Alcaide, et al.. (2019). Update of metastatic colorectal cancer metastases resection after FOLFIRI-aflibercept in oxaliplatin-refractory patients. Annals of Oncology. 30. iv51–iv52. 1 indexed citations

15.

Téllez, Teresa, Francisco Rivas‐Ruiz, Julia Alcaide, et al.. (2018). Factors Associated with Prolonged Patient-Attributable Delay in the Diagnosis of Colorectal Cancer. Cancer Research and Treatment. 50(4). 1270–1280. 12 indexed citations

16.

Godoy-Ortíz, Ana, et al.. (2017). Bevacizumab for recurrent, persistent or advanced cervical cancer: reproducibility of GOG 240 study results in “real world” patients. Clinical & Translational Oncology. 20(7). 922–927. 24 indexed citations

17.

Feliú, Jaime, José Luís Zamora Manzano, Manuel Valladares‐Ayerbes, et al.. (2016). Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain. Clinical & Translational Oncology. 19(4). 498–507. 16 indexed citations

18.

Alcaide, Julia, Antonio Rueda, Elísabeth Pérez-Ruiz, et al.. (2013). The role and prognostic value of apoptosis in colorectal carcinoma. BMC Clinical Pathology. 13(1). 24–24. 32 indexed citations

19.

Pérez-Ruiz, Elísabeth, A. Rueda, Teresa Pereda, et al.. (2012). Involvement of K-RAS mutations and amino acid substitutions in the survival of metastatic colorectal cancer patients. Tumor Biology. 33(6). 1829–1835. 13 indexed citations

20.

Cobo, Manuel, et al.. (2006). Metástasis coroidea como debut de un carcinoma de pulmón no microcítico avanzado. 29(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact